#POLB Poolbeg Pharma PLC – Interim results for the six months to 30 June 2023 September 13, 2023 – Posted in: Blog, Poolbeg Pharma (POLB)

13 September 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announces its unaudited interim results for the six months to 30 June 2023.   Interim Results Highlights and Business Update ·    Strong cash balance of £14.1 million as at 30 June 2023 (31 December 2022: £16.2m) ·    Positive results from the POLB 001 LPS human challenge trial. The asset has the potential to…

Continue reading